Additive effects of tetrocarcin-A and diminazene aceturate concurrently administered against Babesia rodhaini-inoculated mice.
Namikawa
K
K
Sakuma
Y
Y
Sunaga
F
F
Kanno
Y
Y
D000578:Amidines / Q000627:therapeutic use*; D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D001404:Babesiosis / Q000188:drug therapy*; D004133:Diminazene / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use* / Q000633:toxicity; D004338:Drug Combinations; D005260:Female; D051379:Mice
D000578:Amidines; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D004338:Drug Combinations; C025518:tetrocarcin A; C003915:diminazene aceturate; D004133:Diminazene